Naomi M. Hamburg, MD, MS
Joseph A. Vita, MD Professor, Medicine
Biography
Dr. Hamburg is the inaugural Joseph A. Vita Professor of Medicine, Chief of the Vascular Biology Section, interim Director of the Whitaker Cardiovascular Institute at Boston University School of Medicine and an Attending in the Cardiovascular Medicine Section at Boston Medical Center. Dr. Hamburg is a recognized expert in the field of Vascular Medicine and the clinical translation of Vascular Biology. Her research work seeks to understand approaches to restore vascular health in patients with cardiometabolic disorders, peripheral artery disease, and to evaluate the impact of novel tobacco products and long COVID. Her work has been continuously funded by the National Institutes of Health and foundations since 2006. Dr. Hamburg has held multiple leadership positions in the field of Vascular Medicine including as the Chair of the Peripheral Vascular Disease Council of the American Heart Association, and as a member of the Board of the Society of Vascular Medicine, the American Society of Echocardiography and the Vascular Testing Division of the Intersocietal Accreditation Commission. She co-Chaired the Advanced Training Statement for Vascular Medicine from the American College of Cardiology and the Society of Vascular Medicine. Dr. Hamburg has authored more than 150 scientific papers in the peer reviewed literature and has served on guideline writing committees. She is a past Associate Editor of the journal Vascular Medicine, and current Associate Editor for Circulation Research. She is passionate about improving the care of vascular diseases and reducing the burden of PAD through education. When not working, she enjoys spending time in the mountains hiking and skiing with her husband and two teenage sons.
Other Positions
- Section Chief, Vascular Biology, Medicine, Boston University Chobanian & Avedisian School of Medicine
- Investigator, Framingham Heart Study
- Interim Director, Whitaker Cardiovascular Institute, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
Education
- Harvard Medical School, MD
- Harvard University, AB
Publications
- Published on 5/16/2024
Cooper LL, Prescott BR, Xanthakis V, Benjamin EJ, Vasan RS, Hamburg NM, Long MT, Mitchell GF. Association of Aortic Stiffness and Pressure Pulsatility With Noninvasive Estimates of Hepatic Steatosis and Fibrosis: The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2024 Jul; 44(7):1704-1715. PMID: 38752348.
Read at: PubMed - Published on 5/14/2024
Kosyakovsky LB, Liu EE, Wang JK, Myers L, Parekh JK, Knauss H, Lewis GD, Malhotra R, Nayor M, Robbins JM, Gerszten RE, Hamburg NM, McNeill JN, Lau ES, Ho JE. Uncovering Unrecognized Heart Failure With Preserved Ejection Fraction Among Individuals With Obesity and Dyspnea. Circ Heart Fail. 2024 May; 17(5):e011366. PMID: 38742409.
Read at: PubMed - Published on 5/14/2024
Bonaca MP, Hamburg NM, Creager MA. Stepping Into the Future of Care for Patients With Peripheral Artery Disease. Circulation. 2024 Jun 11; 149(24):1862-1864. PMID: 38743808.
Read at: PubMed - Published on 5/8/2024
Boelitz KM, Forsyth A, Crawford A, Simons JP, Siracuse JJ, Farber A, Hamburg N, Eberhardt R, Schanzer A, Jones DW. Polyvascular disease is common in patients undergoing carotid endarterectomy and lower extremity bypass and is associated with worse outcomes. J Vasc Surg. 2024 May 08. PMID: 38723911.
Read at: PubMed - Published on 5/4/2024
Rawal S, Randhawa V, Rizvi SHM, Sachan M, Wara AK, Pérez-Cremades D, Weisbrod RM, Hamburg NM, Feinberg MW. miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signaling. Cardiovasc Res. 2024 May 04. PMID: 38703377.
Read at: PubMed - Published on 4/25/2024
Hamburg NM, Moore KJ. Introduction to the Compendium On Environmental Impacts on Cardiovascular Health and Biology. Circ Res. 2024 Apr 26; 134(9):1047. PMID: 38662857.
Read at: PubMed - Published on 4/25/2024
Blaustein JR, Quisel MJ, Hamburg NM, Wittkopp S. Environmental Impacts on Cardiovascular Health and Biology: An Overview. Circ Res. 2024 Apr 26; 134(9):1048-1060. PMID: 38662864.
Read at: PubMed - Published on 4/20/2024
Yang JY, Mondéjar-Parreño G, Jahng JWS, Lu Y, Hamburg N, Nadeau KC, Conklin DJ, Liao R, Chandy M, Wu JC. Elucidating effects of the environmental pollutant benzo[a]pyrene [BaP] on cardiac arrhythmogenicity. J Mol Cell Cardiol. 2024 Jun; 191:23-26. PMID: 38648962.
Read at: PubMed - Published on 4/19/2024
Minetti ET, Erythropel HC, Keith R, Davis DR, Zimmerman JB, Krishnan-Sarin S, Hamburg NM. Cardiovascular Health Effects and Synthetic Cooling Agents in E-cigarettes Labeled as 'clear' Marketed in Massachusetts After the Tobacco Product Flavoring Ban. medRxiv. 2024 Apr 19. PMID: 38699355.
Read at: PubMed - Published on 4/16/2024
Siracuse JJ, Menard MT, Rosenfield K, Conte MS, Powell R, Hamburg N, Doros G, Strong MB, Farber A. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Apr 16. PMID: 38626847.
Read at: PubMed
View 215 more publications: View full profile at BUMC